LRI Investments »

Tvardi Therapeutics shares owned by LRI Investments

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by LRI Investments from 13F filings

Historical chart of LRI Investments investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by LRI Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by LRI Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $116 27 4.30

More positions owned by LRI Investments

Ares Management Corporation Cl A Com Stk Stock (ARES)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Dimensional Us Core Equity 1 Etf Etf (DCOR)
Dimensional World Ex U.s. Core Equity 2 Etf Etf (DFAX)
Vanguard Ftse All-world Ex-us Index Fund Etf (VEU)
Dimensional International Core Equity Market Etf Etf (DFAI)
Wisdomtree U.s. Largecap Dividend Fund Etf (DLN)
Assured Guaranty Stock (AGO)
Wisdomtree International Equity Fund Etf (DWM)
Microsoft Corp Stock (MSFT)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Meta Platforms Inc Cl A Stock (META)
Apple Stock (AAPL)
Dimensional International Value Etf Etf (DFIV)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for LRI Investments

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
FMR
Duncan Williams Asset Management
Squarepoint Ops
Northern Trust
Jane Street
Farallon Capital Management
UBS Group
Goldman Sachs Group

View all funds holding Tvardi Therapeutics